Compare OTEX & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OTEX | MMED |
|---|---|---|
| Founded | 1991 | 1983 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.5B |
| IPO Year | 1998 | 2025 |
| Metric | OTEX | MMED |
|---|---|---|
| Price | $24.56 | $20.53 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $36.10 | $22.56 |
| AVG Volume (30 Days) | ★ 1.8M | 1.2M |
| Earning Date | 05-07-2026 | 06-03-2026 |
| Dividend Yield | ★ 4.92% | N/A |
| EPS Growth | ★ 56.36 | N/A |
| EPS | ★ 2.58 | N/A |
| Revenue | $2,815,241,000.00 | ★ $3,102,000,000.00 |
| Revenue This Year | $2.82 | $15.99 |
| Revenue Next Year | $1.04 | $10.00 |
| P/E Ratio | $9.63 | ★ N/A |
| Revenue Growth | ★ 22.88 | 14.25 |
| 52 Week Low | $19.78 | $10.65 |
| 52 Week High | $39.90 | $20.88 |
| Indicator | OTEX | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 66.18 |
| Support Level | $21.75 | $10.68 |
| Resistance Level | $25.57 | $20.88 |
| Average True Range (ATR) | 0.89 | 0.89 |
| MACD | -0.11 | -0.05 |
| Stochastic Oscillator | 37.55 | 81.49 |
Open Text Corp provides data management for enterprise AI, offering a secure data foundation and trusted context for credible AI outcomes across private, public, and sovereign cloud, managed cloud services, API, and on-premises environments. The Company also provides cybersecurity solutions to protect sensitive data, applications and systems across complex hybrid environments, including identity and access management, threat detection and response, data protection and application security. It serves private, public, and regulated sectors, including retail, financial services, government, manufacturing, healthcare, energy, and logistics, with clients. Geographically, it derives maximum revenue from the Americas.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.